McLaren Cancer Institute-Bay City
Bay City, Michigan, United States
Cancer treatment center in Bangor Township, Michigan
3140 W Campus Dr, Bay City, MI 48706
About McLaren Cancer Institute-Bay City
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
24
NRG Oncology
10
Alliance for Clinical Trials in Oncology
9
SWOG Cancer Research Network
7
ECOG-ACRIN Cancer Research Group
5
Barbara Ann Karmanos Cancer Institute
2
GOG Foundation
1
Radiation Therapy Oncology Group
1
Clinical Trials at McLaren Cancer Institute-Bay City
During the past decade, McLaren Cancer Institute-Bay City conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 13 clinical trials were completed, i.e. on
average, 31.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 8 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
2008-02-25
Active, not recruiting
165
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
2008-05-15
Active, not recruiting
394
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
2010-09-15
2017-12-16
Terminated
77
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
2011-01-15
2024-03-07
Active, not recruiting
5,083
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "McLaren Cancer Institute-Bay City" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "NRG Oncology" with 10 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 7 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "McLaren Cancer Institute-Bay City"
#1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at McLaren Cancer Institute-Bay City
According to Clinical.Site data, the most researched conditions in "McLaren Cancer Institute-Bay City" are
"Invasive Breast Carcinoma" (5 trials), "Stage II Breast Cancer" (4 trials), "Stage IIIA Breast Cancer" (4 trials), "Stage IV Breast Cancer AJCC v6 and v7" (4 trials) and "Colon Adenocarcinoma" (3 trials). Many other conditions were trialed in "McLaren Cancer Institute-Bay City" in a lesser frequency.
Clinical Trials Intervention Types at McLaren Cancer Institute-Bay City
Most popular intervention types in "McLaren Cancer Institute-Bay City" are "Drug" (43 trials), "Other" (40 trials), "Radiation" (25 trials), "Biological" (19 trials) and "Procedure" (13 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (23 trials), "Laboratory Biomarker Analysis" (20 trials), "Questionnaire Administration" (16 trials), "Intensity-Modulated Radiation Therapy" (11 trials) and "Fluorouracil" (10 trials). Other intervention names were less common.
Clinical Trials Genders at McLaren Cancer Institute-Bay City
The vast majority of trials in "McLaren Cancer Institute-Bay City" are
46 trials for "All" genders, 9 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at McLaren Cancer Institute-Bay City
Currently, there are NaN active trials in "McLaren Cancer Institute-Bay City".
undefined are not yet recruiting,
16 are recruiting,
35 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in McLaren Cancer Institute-Bay City,
3 suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in McLaren Cancer Institute-Bay City, 2 "Phase 1"
clinical trials were conducted, 20 "Phase 2" clinical
trials and 41 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".